Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device
Notal Vision, Inc. announced today that the company initiated the first US-based study using its investigational home-based optical coherence tomography (OCT) platform. The study will evaluate the ability of subjects with wet age-related macular degeneration (AMD) to perform sequential daily self-imaging of their eyes with the user-friendly, self-operated Notal Home OCT device in their homes. The Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet AMD, complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. “Remote OCT monitoring of wet AMD ...
Login to comment.